发明名称 |
STABILIZATION IMMUNOREGULATION RNA (SIMRA) COMPOUND FOR TLR7 AND TLR8 |
摘要 |
PROBLEM TO BE SOLVED: To provide oligoribonucleotide (RNA) having stability to nuclease and RNase and immunoregulation activity through TLR7 and/or TLR8.SOLUTION: A stabilization immunoregulation RNA (SIMRA) compound is an agonist to TLR8, TLR7 and TLR8, or TLR7, where the SIMRA comprises at least two RNA-based oligonucleotides bound through 3' or 5' attachment or a combination thereof, or the RNA-based oligonucleotides are directly bound to each other at 3' terminal or 5' terminal. Or, the RNA-based oligonucleotides are bound to a non-nucleotide linker at 3' terminal or 5' terminal, and the non-nucleotide linker is an alkyl linker or an amino linker. |
申请公布号 |
JP2014031373(A) |
申请公布日期 |
2014.02.20 |
申请号 |
JP20130160852 |
申请日期 |
2013.08.01 |
申请人 |
IDERA PHARMACEUTICALS INC |
发明人 |
KANDIMALLA EKAMBAR R;LAN TAO;LI YUKUI;YU DONG;DAQING WANG;PUTTA MALLIKARJUNA REDDY;AGRAWAL SUDHIR |
分类号 |
A61K31/7105;A61K31/711;A61K39/00;A61K39/395;A61K45/00;A61K48/00;A61P11/00;A61P11/06;A61P17/00;A61P29/00;A61P31/00;A61P31/04;A61P31/12;A61P33/00;A61P35/00;A61P37/04;A61P37/06;A61P37/08;A61P43/00;C12N15/09;C12N15/113;C12N15/117 |
主分类号 |
A61K31/7105 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|